Plain-English translation of NCT07724990 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a probiotic treatment called A. muciniphila to see if it can help restore balance to the gut bacteria of people with mild-to-moderate ulcerative colitis. Researchers believe that this beneficial bacteria may help reduce inflammation and improve symptoms by rebalancing the gut microbiota. The study will follow 20 participants to see how the treatment affects their gut health and disease activity.
Ulcerative colitis happens when the gut bacteria become imbalanced, which can trigger inflammation and symptoms. While traditional probiotics have been used for decades, this medication is being specifically developed as a treatment for inflammatory bowel disease, and researchers want to gather solid clinical evidence about whether this approach actually works in patients.
You likely qualify if…
You likely don't qualify if…
Participants will receive the beneficial bacteria treatment, likely as a rectal enema or similar form, as part of their regular medical care for ulcerative colitis. You will attend screening and baseline visits where your gut health and disease activity will be evaluated using endoscopy and stool samples. Throughout the study, you will continue taking your current ulcerative colitis medications (like corticosteroids or mesalazine) and follow the study schedule to allow researchers to track how the treatment affects your gut bacteria balance and symptoms.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
Italy